https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png 0 0 Lianna Palkovick https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Lianna Palkovick2017-05-29 09:18:532017-05-30 09:20:05Skin Cancer
May is National Melanoma/Skin Cancer Detection and Prevention Month and the story here is reasonably positive. Most people know that melanoma is a worrisome cancer but the good news is that 84% present…
http://treatcancer.com/wp-content/uploads/2016/01/EbolaVirus.jpg 1920 2560 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-30 21:55:252016-01-06 22:11:10Scientists use Lassa-VSV, a combination of deadly viruses, to fight brain tumors
Scientists looking for new treatments for patients with brain tumors, including those caused by metastatic melanoma, have turned to an unlikely source: a deadly tropical virus. The virus, called Lassa, causes a deadly hemorrhagic fever endemic to West Africa. A team of cancer scientists from Yale and Harvard are altering part of the virus's genetic code, combining it with a different virus, and injecting it into the human brain where they hope it can be used to find and destroy cancer cells.
http://treatcancer.com/wp-content/uploads/2016/01/mortar-and-pestle.jpeg 282 425 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-24 19:53:272016-01-06 22:13:30New cancer drug binimetinib shows success in late stage trial
On December 16, Array BioPharma announced its new cancer drug, binimetinib, showed success in stage 3 clinical trials. According to the drug company, binimetinib may be used to treat people with advanced NRAS-mutant melanoma, a particularly deadly form of skin cancer. The trial showed that the drug extended the time it takes for cancer to grow and spread.
http://treatcancer.com/wp-content/uploads/2016/01/tanningbed.jpg 672 801 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-20 18:26:122016-01-06 22:14:46FDA proposes ban on indoor tanning for minors
Indoor tanning ban aimed at reducing skin cancer rates in minors. On December 18, in a sweeping move in the fight against skin cancer, the FDA proposed a national ban on indoor tanning for people under the age of 18. Medical experts have called the move an important step in reducing the risk of skin cancer in the United States.
http://treatcancer.com/wp-content/uploads/2015/12/Immunotherapy.jpg 2466 2356 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-19 22:37:122015-12-22 18:31:06Types of Immunotherapy
Immunotherapy refers to a type of cancer treatment that attempts to stimulate the body's immune system to attack and kill cancer cells. The immune system is the body's natural defense against germs and disease. The main components of the immune system are the organs, tissues, and fluids that make up the lymph system—including white blood cells. White blood cells, such as T cells, are the substances that actually attack and kill germs or other unhealthy substances, such as cancer cells.
http://treatcancer.com/wp-content/uploads/2015/12/Healthy_Human_T_Cell.jpg 1884 1884 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-16 22:31:592015-12-21 22:32:49What is Immunotherapy?
Melanoma is a type of skin cancer caused by damage to the DNA of melanocyte cells in the skin. Melanocytes produce melanin, a pigment in skin that is primarily responsible for skin color. When melanocytes DNA is damaged, it may cause the cells to mutate—leading to rapid, uncontrolled growth and the formation of malignant tumors. The goal of immunotherapy for cancer is to overcome these barriers to an effective anticancer immune response. These biological therapies restore or increase the activities of specific immune-system components or counteract immunosuppressive signals produced by cancer cells.
http://treatcancer.com/wp-content/uploads/2015/12/Metastatic_Melanoma_Cells_Nci-vol-9872-300.jpg 3000 3000 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-11 21:33:522015-12-21 21:43:14Cancer News: FDA Approves Pembrolizumab as Standard of Care in Advanced Melanoma
Pembrolizumab (marketed under the brand name Keytruda by Merck) works by short circuiting the mechanism that slows down or stops the body's immune system. In doing so, the drug allows T cells—the body's natural defenders against disease—to recognize, attack, and kill cancer cells.
http://treatcancer.com/wp-content/uploads/2015/12/Kaposi_sarcoma_high_mag.jpg 2848 4272 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-09 00:10:542015-12-16 00:51:18Treatment of Kaposi Sarcoma
A handful of different treatment options are available for patients with Kaposi sarcoma. Treatment options are largely determined by the type of Kaposi sarcoma, the overall health of the patient, and whether the disease is being diagnosed for the first time or if it has come back after initial treatments.
http://treatcancer.com/wp-content/uploads/2015/12/Kaposis_Sarcoma_Lesions.jpg 675 1012 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-05 23:48:272015-12-16 00:09:40What is Kaposi Sarcoma?
Kaposi sarcoma is rare type of cancer that causes tumors to form in the skin; mucous membranes lining the mouth, nose, and throat; lymph nodes; or other organs. Tumors caused by Kaposi sarcoma are usually purple and are made of cancer cells, new blood vessels, red blood cells, and white blood cells. Most cancers begin in one part of the body and spread to others; in the case Kaposi sarcoma, lesions may begin in more than one place in the body at the same time.
http://treatcancer.com/wp-content/uploads/2015/12/Gray602.png 505 500 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-01 23:29:522015-12-15 23:41:53Skin Lymphoma
Skin lymphoma is a rare type of cancer that originates in white blood cells in the skin. Lymphoma is a type of cancer that develops in white blood cells called lymphocytes. Lymphocytes are an integral part of the body’s immune system. They are found in lymph nodes, which are small clusters of immune tissue located at various locations throughout the body, as well as in other areas of the body, such as the bone marrow, spleen, and other organs, including the skin.